654676-62-7 Usage
Description
5H-Cyclopenta[b]pyridin-6-amine,6,7-dihydro-(9CI) is an organic compound that serves as a crucial intermediate in the synthesis of various pharmaceutical and biological compounds, particularly those with potential applications in the treatment of cancer.
Uses
Used in Pharmaceutical Industry:
5H-Cyclopenta[b]pyridin-6-amine,6,7-dihydro-(9CI) is used as a key intermediate for the synthesis of anticancer agents. Its unique chemical structure allows for the development of novel compounds that can target and inhibit specific cancer-related pathways, making it a valuable asset in the fight against various types of cancer.
Used in Drug Development:
In the field of drug development, 5H-Cyclopenta[b]pyridin-6-amine,6,7-dihydro-(9CI) plays a significant role in the creation of new therapeutic agents. Its versatile chemical properties enable researchers to design and synthesize a wide range of biologically active molecules with potential applications in cancer treatment and other medical areas.
Used in Research and Development:
5H-Cyclopenta[b]pyridin-6-amine,6,7-dihydro-(9CI) is also utilized in research and development laboratories for the study of its chemical properties and potential interactions with various biological targets. This helps in the discovery of new drug candidates and the optimization of their pharmacological profiles for improved efficacy and safety.
Check Digit Verification of cas no
The CAS Registry Mumber 654676-62-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,5,4,6,7 and 6 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 654676-62:
(8*6)+(7*5)+(6*4)+(5*6)+(4*7)+(3*6)+(2*6)+(1*2)=197
197 % 10 = 7
So 654676-62-7 is a valid CAS Registry Number.
654676-62-7Relevant articles and documents
QUINOLINE-2-ONE-DERIVATIVES FOR THE TREATMENT OF AIRWAYS DISEASES
-
Page/Page column 65, (2008/06/13)
Compounds of formula (I) in free or salt form, wherein -C-Y-, R1 and R2 are G have the meanings as indicated in the specification, are useful for treating conditions that are prevented or alleviated by activation of the (β2-adrenoreceptor. Pharmaceutical compositions that contain the compounds and a process for preparing the compounds are also described.
